Evofem Announces Karina Fedasz as Company's New Head of Business Development

Fedasz will Focus on Opening New Markets for Evofem's First - and Only – in-Class Contraceptive, Phexxi® (lactic acid, citric acid, and potassium bitartrate) SAN DIEGO, April 11, 2022 -- (Healthcare Sales & Marketing Network) -- Evofem Biosciences,... Biopharmaceuticals, Personnel Evofem Biosciences, Phexxi
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news